The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute decompensated cirrhosis, and 2-26% in post-liver transplant patients.
Medtronic will distribute Allurion’s swallowable weight-loss balloon
Dive Brief: Allurion, maker of a swallowable gastric balloon designed to facilitate weight loss, said it has partnered with Medtronic in a pilot agreement to
June 22, 2023